Submitted by Anonymous (not verified) on 15 September 2023 - 11:00
Guideline on safety and efficacy data requirements for 4 applications for immunological veterinary medicinal 5 products intended for limited markets but not eligible 6 for authorisation under Article 23 of Regulation (EU) 7 2019/6
Source: